SCHEMBL5797776

SCHEMBL5797776

COc1cc2c(-c3cc(Cl)c(F)[nH]3)cn(CCN3CCOCC3)c2cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
RCE1 Q9Y256 1/20 0.44
KDR P35968 2/20 0.42
GSK3B P49841 1/20 0.42
EGFR P00533 4/20 0.41
MAPK1 P28482 2/20 0.41
CCNT1 O60563 4/20 0.40
CDK9 P50750 4/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CNR1 P21554 2/20 0.38
KMT2A Q03164 1/20 0.38
CIT O14578 1/20 0.38
GAK O14976 1/20 0.38
EPHB6 O15197 1/20 0.38
ABCC4 O15439 1/20 0.38
DAPK3 O43293 1/20 0.38
RIPK2 O43353 1/20 0.38
NR1I2 O75469 1/20 0.38
RPS6KA4 O75676 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5796552 0.84 KDR (0.45) KDM4ERCE1KDRGSK3BMAPK1
SCHEMBL1749184 0.82 CDK9 (0.43) KDM4ERCE1KDREGFRCCNT1
SCHEMBL5793991 0.82 KDR (0.43) KDM4ERCE1KDRGSK3BEGFR
SCHEMBL1748609 0.81 CDK9 (0.47) KDM4ERCE1KDRGSK3BEGFR
SCHEMBL1748831 0.79 IGF1R (0.46) KDM4ERCE1KDRGSK3BEGFR
SCHEMBL1779928 0.76 IGF1R (0.66) KDM4ERCE1KDRGSK3BCCNT1
SCHEMBL5794491 0.74 GSK3B (0.39) KDM4ERCE1KDRGSK3BEGFR
SCHEMBL1748870 0.72 IGF1R (0.46) KDRGSK3BEGFRCCNT1CDK9
SCHEMBL5794570 0.72 TP53 (0.41) KDM4EKDRGSK3BEGFRALDH1A1
SCHEMBL5795213 0.72 KDR (0.37) KDM4EKDRGSK3BEGFRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732546-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS Aventis Pharma S.A. (FR) 2006-12-20 EP disclosed
WO-2005095399-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2005-10-13 WO disclosed